Loncar Cancer Immunotherapy ETF (%)
(CNCR)Years | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 4.75 | 22.18 | -3.6 | -11.91 | -0.61 | 0 | ||||||
2023 | 8.15 | -9.42 | -10.86 | 5.5 | 5.07 | -2.78 | 0.15 | -7.11 | -8.86 | -11.64 | 13.69 | 22.4 |
2022 | -18.55 | -4.92 | -2.33 | -14.02 | -10.07 | 9.14 | 5.33 | -3.08 | -5.51 | 2.37 | -0.6 | -7.91 |
2021 | 1.4 | 8.78 | 6.02 | 5.1 | 1.45 | -2.21 | 0.5 | 2.36 | -3.49 | 4.36 | -1.84 | 5.63 |
2020 | -10.04 | 2.67 | -9.77 | 16.33 | 16.58 | 2.25 | -6.91 | 5.75 | 175.4 | 4.79 | 2.69 | -45.64 |